Michael G. Hennerici
Heidelberg University
508 Papers
4.4K Citations
Michael G. Hennerici is an academic researcher from Heidelberg University. The author has contributed to research in topics: Stroke & Medicine. The author has an hindex of 81, co-authored 504 publications. Previous affiliations of Michael G. Hennerici include University of Düsseldorf.
Chat about Author
Papers
Guidelines for management of ischaemic stroke and transient ischaemic attack 2008
Peter A. Ringleb,Marie-Germaine Bousser,Gary A. Ford,Philip M.W. Bath,Michael Brainin,Valeria Caso,Álvaro Cervera,Ángel Chamorro,Charlotte Cordonnier,László Csiba,Antoni Dávalos,Hans-Christoph Diener,José M. Ferro,Werner Hacke,Michael G. Hennerici,Markku Kaste,Peter Langhorne,Kennedy R. Lees,Didier Leys,J. Lodder,Hugh S. Markus,Jean-Louis Mas,Heinrich Mattle,Keith W. Muir,Bo Norrving,Victor Obach,Stefano Paolucci,E. Bernd Ringelstein,Peter D. Schellinger,Juhani Sivenius,Skvortsova Vi,Katharina S. Sunnerhagen,Lars Thomassen,Danilo Toni,Rüdiger von Kummer,Nils Wahlgren,Marion F Walker,Joanna M. Wardlaw +37 more
TL;DR: The article covers referral and emergency management, Stroke Unit service, diagnostics, primary and secondary prevention, general stroke treatment, specific treatment including acute management, management of complications, and rehabilitation.
Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study
Nils Wahlgren,Niaz Ahmed,Antoni Dávalos,Gary A. Ford,Martin Grond,Werner Hacke,Michael G. Hennerici,Markku Kaste,Sonja Kuelkens,Vincent Larrue,Kennedy R. Lees,Risto O. Roine,Lauri Soinne,Danilo Toni,Geert Vanhooren +14 more
TL;DR: These data confirm that intravenous alteplase is safe and effective in routine clinical use when used within 3 h of stroke onset, even by centres with little previous experience of thrombolytic therapy for acute stroke.
2K
30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial.
Peter A. Ringleb,Jens-Rainer Allenberg,Hartmut Brückmann,Hans-Henning Eckstein,Gustav Fraedrich,Maximilian Hartmann,Michael G. Hennerici,Olav Jansen,Klein G,A. Kunze,Marx P,Kurt Niederkorn,Schmiedt W,Laszlo Solymosi,Robert Stingele,Hermann Zeumer,Werner Hacke +16 more
TL;DR: In this paper, Carotid endarterectomy is effective in stroke prevention for patients with severe symptomatic carotid-artery stenosis, and Stentation has been widely used as alternative treatment.
1.5K
Impaired Clearance of Emboli (Washout) Is an Important Link Between Hypoperfusion, Embolism, and Ischemic Stroke
TL;DR: It is posited that impaired washout is an important but neglected concept that intertwines hypoperfusion, embolization, and brain infarction.
897
Results of the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE) study to treat symptomatic stenoses at 2 years: a multinational, prospective, randomised trial.
Hans-Henning Eckstein,Peter A. Ringleb,Jens-Rainer Allenberg,Jürgen Berger,Gustav Fraedrich,Werner Hacke,Michael G. Hennerici,Robert Stingele,Jens Fiehler,Hermann Zeumer,Olav Jansen +10 more
TL;DR: After 2 years' follow-up, the rate of recurrent ipsilateral ischaemic strokes reported in the SPACE trial is similar for both treatment groups, and it cannot be excluded that the degree of in-stent stenosis is slightly overestimated by conventional ultrasound criteria.
876